Comprehensive macro and micro views on immune cells in ischemic heart disease

Area of Science:

• Cardiovascular Science
• Immunology
• Pathophysiology

Background:

• Ischemic heart disease (IHD) is a leading cause of death, characterized by adverse ventricular remodeling and heart failure.
• The cardiovascular and immune systems are interconnected, with immune cells significantly impacting cardiac health and disease.
• Cardiac microenvironment alterations in IHD are modulated by immune cells like macrophages, neutrophils, and T-lymphocytes, and their secreted cytokines.

Purpose of the Study:

• To review the multifaceted roles of immune cells in inflammatory responses and myocardial repair following IHD.
• To explore the significance of specific immune cells, such as Gata6+ pericardial macrophages, in regulating cardiac repair post-IHD.
• To discuss novel immune cell-based therapeutic strategies for IHD.

Main Methods:

• Literature review synthesizing current research on immune cell involvement in IHD.
• Analysis of both macro and micro perspectives on immune cell functions in cardiac pathophysiology.
• Examination of emerging therapeutic approaches targeting immune cells for IHD treatment.

Main Results:

• Immune cells, including macrophages and T-lymphocytes, are key players in orchestrating inflammation and tissue repair after myocardial infarction.
• Gata6+ pericardial macrophages are identified as critical regulators of immune cell migration and myocardial healing.
• The interplay between immune responses and cardiac remodeling is central to IHD progression and resolution.

Conclusions:

• Immune cell activity critically influences the progression and resolution of ischemic heart disease.
• Targeting specific immune cells and their pathways presents a promising avenue for novel IHD therapies.
• Further research into immune cell-based strategies holds potential for improving outcomes in patients with ischemic heart disease.